StockData
Upstream Bio, Inc. logo

Upstream Bio, Inc. (UPB) stock

UPBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/30
$2.10−0.05 (-2.33%)

Close on Nov 17, 2026Market cap $115.02MP/E –Yield –

Upstream Bio pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

No pe ratio figures for Upstream Bio

Upstream Bio has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Upstream Bio figures

See a number that looks wrong?